Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Laws

Showing results (221-230 of 309) with videos related to

Pageof 31
Sort By:
International Psychogeriatrics|July 20, 2017
BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNFYen Ying Lim, Stephanie Rainey-Smith, Yoon Lim, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 20, 2020
Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical PipelineWen Kang, Alexei A Podtelezhnikov, Keith Q Tanis, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 16, 2016
β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and MenSophie E Holmes, Irina Esterlis, Carolyn M Mazure, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal StudyTenielle Porter, Samantha C Burnham, Lidija Milicic, et al.
Neurobiology of Aging|February 5, 2019
Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's diseaseTenielle Porter, Samantha C Burnham, Lidija Milicic, et al.
Neurobiology of Aging|July 18, 2018
Estimates of age-related memory decline are inflated by unrecognized Alzheimer's diseaseKarra D Harrington, Adrian Schembri, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD|September 28, 2020
Comorbidity of Cerebrovascular and Alzheimer's Disease in AgingYing Xia, Nawaf Yassi, Parnesh Raniga, et al.
Rheumatology (Oxford, England)|December 9, 2025
Development of a psoriatic arthritis - like presentation under anti - IL-13 therapy with tralokinumab for atopic dermatitisKatya Meridor, Sook Yan Lee, Ilona Blee, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older AdultsChrista Dang, Karra D Harrington, Yen Ying Lim, et al.
Neurology|August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-upSamantha C Burnham, Christopher C Rowe, David Baker, et al.
Pageof 31

Showing results (221-230 of 309) with videos related to

Sort By:
Pageof 31
International Psychogeriatrics|July 20, 2017
BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNFYen Ying Lim, Stephanie Rainey-Smith, Yoon Lim, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 20, 2020
Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical PipelineWen Kang, Alexei A Podtelezhnikov, Keith Q Tanis, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 16, 2016
β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and MenSophie E Holmes, Irina Esterlis, Carolyn M Mazure, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal StudyTenielle Porter, Samantha C Burnham, Lidija Milicic, et al.
Neurobiology of Aging|February 5, 2019
Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's diseaseTenielle Porter, Samantha C Burnham, Lidija Milicic, et al.
Neurobiology of Aging|July 18, 2018
Estimates of age-related memory decline are inflated by unrecognized Alzheimer's diseaseKarra D Harrington, Adrian Schembri, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD|September 28, 2020
Comorbidity of Cerebrovascular and Alzheimer's Disease in AgingYing Xia, Nawaf Yassi, Parnesh Raniga, et al.
Rheumatology (Oxford, England)|December 9, 2025
Development of a psoriatic arthritis - like presentation under anti - IL-13 therapy with tralokinumab for atopic dermatitisKatya Meridor, Sook Yan Lee, Ilona Blee, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older AdultsChrista Dang, Karra D Harrington, Yen Ying Lim, et al.
Neurology|August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-upSamantha C Burnham, Christopher C Rowe, David Baker, et al.
Pageof 31